Bio-Techne (TECH) FCF Payout Ratio Growth (1y) (2010 - 2026)
Bio-Techne (TECH) FCF Payout Ratio Growth (1y) (2010 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Cover Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 68.88% |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | - |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | - |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | -31.89% |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | - |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | - |
| 10 | Bio-Techne | 11.33 Bn | 11.12 Bn | 208.29 Mn | -60.24% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -60.24% |
| Dec 31, 2025 | -0.76% |
| Sep 30, 2025 | 141.49% |
| Jun 30, 2025 | -39.53% |
| Mar 31, 2025 | 108.25% |
| Dec 31, 2024 | -10.72% |
| Sep 30, 2024 | -16.09% |
| Jun 30, 2024 | 26.46% |
| Mar 31, 2024 | -39.92% |
| Dec 31, 2023 | -14.63% |
| Sep 30, 2023 | 2.49% |
| Jun 30, 2023 | 23.42% |
| Mar 31, 2023 | 49.67% |
| Dec 31, 2022 | 55.67% |
| Sep 30, 2022 | -8.56% |
| Jun 30, 2022 | 25.09% |
| Mar 31, 2022 | 11.91% |
| Dec 31, 2021 | -13.04% |
| Sep 30, 2021 | 31.65% |
| Jun 30, 2021 | -74.85% |